Key approaches to nosocomial infection control

1Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009; 64 (Suppl 1):i3-10. HawkeyPMJonesAMThe changing epidemiology of resistanceJ Antimicrob Chemother2009 64Suppl 1i31010.1093/jac/dkp256Search in Google Scholar

2Ramesh N, Prasanth M, Ramkumar S, Suresh M, Tamhankar AJ, Gothandam KM, et al. Colistin susceptibility of gram-negative clinical isolates from Tamil Nadu, India. Asian Biomed. 2016; 10:35-9. RameshNPrasanthMRamkumarSSureshMTamhankarAJGothandamKMet alColistin susceptibility of gram-negative clinical isolates from Tamil Nadu, IndiaAsian Biomed2016 10359Search in Google Scholar

3Magill SS, Edwards JR, Fridkin SK. Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. Multistate point-prevalence survey of health care-associated infections. N Eng l J Med. 2014; 370:2542-3. MagillSSEdwardsJRFridkinSKEmerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. Multistate point-prevalence survey of health care-associated infectionsN Engl J Med2014 3702542310.1056/NEJMc1405194Search in Google Scholar

4Marchetti A, Rossiter R. Economic burden of healthcare-associated infection in US acute care hospitals: societal perspective. J Med Econ. 2013; 16:1399-404. MarchettiARossiterREconomic burden of healthcare-associated infection in US acute care hospitals: societal perspectiveJ Med Econ2013 16139940410.3111/13696998.2013.842922Search in Google Scholar

5Garner JS. Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1996; 24:24-31. GarnerJSGuideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory CommitteeAm J Infect Control1996 24243110.1016/S0196-6553(96)90050-4Search in Google Scholar

6Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control. 1996; 24:313-42. RutalaWAAPIC guideline for selection and use of disinfectantsAm J Infect Control1996 243134210.1016/S0196-6553(96)90066-8Search in Google Scholar

7Rutala WA, Weber DJ. Surface disinfection: should we do it? J Hosp Infect. 2001; 48(Suppl A):S64-8. RutalaWAWeberDJSurface disinfectionshould we do it?J Hosp Infect 2001Suppl A4810.1016/S0195-6701(01)90017-9Search in Google Scholar

8Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013; 26:338-44. WeberDJAndersonDRutalaWAThe role of the surface environment in healthcare-associated infectionsCurr Opin Infect Dis2013 263384410.1097/QCO.0b013e3283630f0423743816Search in Google Scholar

9Gaynes R, Richards C, Edwards J, Emori TG, Horan T, Alonso-Echanove J, et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis. 2001; 7:295-8. GaynesRRichardsCEdwardsJEmoriTGHoranTAlonso-EchanoveJet alFeeding back surveillance data to prevent hospital-acquired infectionsEmerg Infect Dis2001 7295810.3201/eid0702.010230263172411294727Search in Google Scholar

10Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH. Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect. 2005; 60:46-50. EngelhartSTHanses-DerendorfLExnerMKramerMHProspective surveillance for healthcare-associated infections in German nursing home residentsJ Hosp Infect2005 60465010.1016/j.jhin.2004.09.03715823656Search in Google Scholar

11Avcioglu NH, Bilkay IS. Antibiotic resistance, multidrug resistance and enterobacterial repetitive intergenic consensus polymerase chain reaction profiles of clinically important Klebsiella species. Asian Biomed. 2016; 10:41-7. AvciogluNHBilkayISAntibiotic resistance, multidrug resistance and enterobacterial repetitive intergenic consensus polymerase chain reaction profiles of clinically important Klebsiella speciesAsian Biomed2016 10417Search in Google Scholar